Bentley Pharmaceuticals, Inc. (NYSE: BNT), atechnology-based specialty pharmaceutical and drug delivery companywith a growing branded and generic product line in Europe, todayannounced that John A. Sedor, President of the Company, will bepresenting at the Rodman & Renshaw TechVest 7th Annual HealthcareConference at the New York Palace Hotel in New York. The presentationis scheduled for Wednesday, November 9, 2005 at 1:00 p.m. (EasternTime).
The presentation will be broadcast live over the Internet viahttp://www.wsw.com/webcast/rrshq7/bnt/. It may also be accessed viathe Company's web site, www.bentleypharm.com.
Bentley Pharmaceuticals, Inc. is a specialty pharmaceuticalcompany focused on advanced drug delivery technologies andpharmaceutical products. Bentley's proprietary drug technologiesenhance or facilitate the absorption of pharmaceutical compoundsacross various membranes. Bentley also manufactures and markets agrowing portfolio of generic and branded pharmaceuticals in Europe forthe treatment of cardiovascular, gastrointestinal, infectious andneurological diseases through its subsidiaries, Laboratorios Belmac,Laboratorios Davur and Laboratorios Rimafar; and manufactures andmarkets active pharmaceutical ingredients through its subsidiary,Bentley API.
Copies of Bentley Pharmaceuticals' press releases and otherinformation may be obtained through Bentley's web site atwww.bentleypharm.com.
